S&P 500   3,929.23 (-3.90%)
DOW   31,545.65 (-3.40%)
QQQ   292.61 (-4.43%)
AAPL   141.27 (-5.34%)
MSFT   255.80 (-4.13%)
FB   194.22 (-4.15%)
GOOGL   2,259.15 (-3.02%)
AMZN   2,159.00 (-6.43%)
TSLA   707.13 (-7.15%)
NVDA   170.51 (-6.19%)
BABA   87.86 (-4.49%)
NIO   15.86 (-4.63%)
AMD   97.11 (-5.23%)
CGC   5.65 (-4.07%)
MU   71.36 (-4.19%)
T   20.33 (-1.17%)
GE   75.17 (-1.61%)
F   12.84 (-5.10%)
DIS   105.05 (-3.30%)
AMC   12.73 (-1.32%)
PFE   50.53 (-1.58%)
PYPL   77.24 (-3.15%)
NFLX   178.48 (-6.34%)
S&P 500   3,929.23 (-3.90%)
DOW   31,545.65 (-3.40%)
QQQ   292.61 (-4.43%)
AAPL   141.27 (-5.34%)
MSFT   255.80 (-4.13%)
FB   194.22 (-4.15%)
GOOGL   2,259.15 (-3.02%)
AMZN   2,159.00 (-6.43%)
TSLA   707.13 (-7.15%)
NVDA   170.51 (-6.19%)
BABA   87.86 (-4.49%)
NIO   15.86 (-4.63%)
AMD   97.11 (-5.23%)
CGC   5.65 (-4.07%)
MU   71.36 (-4.19%)
T   20.33 (-1.17%)
GE   75.17 (-1.61%)
F   12.84 (-5.10%)
DIS   105.05 (-3.30%)
AMC   12.73 (-1.32%)
PFE   50.53 (-1.58%)
PYPL   77.24 (-3.15%)
NFLX   178.48 (-6.34%)
S&P 500   3,929.23 (-3.90%)
DOW   31,545.65 (-3.40%)
QQQ   292.61 (-4.43%)
AAPL   141.27 (-5.34%)
MSFT   255.80 (-4.13%)
FB   194.22 (-4.15%)
GOOGL   2,259.15 (-3.02%)
AMZN   2,159.00 (-6.43%)
TSLA   707.13 (-7.15%)
NVDA   170.51 (-6.19%)
BABA   87.86 (-4.49%)
NIO   15.86 (-4.63%)
AMD   97.11 (-5.23%)
CGC   5.65 (-4.07%)
MU   71.36 (-4.19%)
T   20.33 (-1.17%)
GE   75.17 (-1.61%)
F   12.84 (-5.10%)
DIS   105.05 (-3.30%)
AMC   12.73 (-1.32%)
PFE   50.53 (-1.58%)
PYPL   77.24 (-3.15%)
NFLX   178.48 (-6.34%)
S&P 500   3,929.23 (-3.90%)
DOW   31,545.65 (-3.40%)
QQQ   292.61 (-4.43%)
AAPL   141.27 (-5.34%)
MSFT   255.80 (-4.13%)
FB   194.22 (-4.15%)
GOOGL   2,259.15 (-3.02%)
AMZN   2,159.00 (-6.43%)
TSLA   707.13 (-7.15%)
NVDA   170.51 (-6.19%)
BABA   87.86 (-4.49%)
NIO   15.86 (-4.63%)
AMD   97.11 (-5.23%)
CGC   5.65 (-4.07%)
MU   71.36 (-4.19%)
T   20.33 (-1.17%)
GE   75.17 (-1.61%)
F   12.84 (-5.10%)
DIS   105.05 (-3.30%)
AMC   12.73 (-1.32%)
PFE   50.53 (-1.58%)
PYPL   77.24 (-3.15%)
NFLX   178.48 (-6.34%)
OTCMKTS:NUGS

Cannabis Strategic Ventures (NUGS) Stock Forecast, Price & News

$0.02
0.00 (-10.50%)
(As of 05/17/2022 03:57 PM ET)
Add
Compare
Today's Range
$0.02
$0.02
50-Day Range
$0.02
$0.03
52-Week Range
$0.01
$0.09
Volume
460,342 shs
Average Volume
1.19 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive NUGS News and Ratings via Email

Sign-up to receive the latest news and ratings for Cannabis Strategic Ventures and its competitors with MarketBeat's FREE daily newsletter.

Cannabis Strategic Ventures logo

About Cannabis Strategic Ventures

Cannabis Strategic Ventures engages in the cultivation of marijuana products in the United States. It incubates, develops, and partners within the cannabis and ancillary sectors. The company is based in Los Angeles, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers—Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:NUGS
Fax
N/A
Employees
30
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













Cannabis Strategic Ventures (OTCMKTS:NUGS) Frequently Asked Questions

Who are Cannabis Strategic Ventures' key executives?
Cannabis Strategic Ventures' management team includes the following people:
  • Mr. Simon Yu M.B.A., Chief Exec. Officer (Age 40)
  • Paul Hutchin, Pres
  • Ms. Arlene Guzman, VP of Operations
  • Mr. John Vu, Legal Counsel
  • J. Brown, Sec. and Director
What other stocks do shareholders of Cannabis Strategic Ventures own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cannabis Strategic Ventures investors own include Aphria (APHA), Annovis Bio (ANVS), Amex Exploration (AMX), Amyris (AMRS), (AMPE), (ALLIF), Aleafia Health (ALEAF), Aldeyra Therapeutics (ALDX), Agraflora Organics International (AGRA) and Acreage (ACRGF).

What is Cannabis Strategic Ventures' stock symbol?

Cannabis Strategic Ventures trades on the OTCMKTS under the ticker symbol "NUGS."

How do I buy shares of Cannabis Strategic Ventures?

Shares of NUGS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cannabis Strategic Ventures' stock price today?

One share of NUGS stock can currently be purchased for approximately $0.02.

How many employees does Cannabis Strategic Ventures have?

Cannabis Strategic Ventures employs 30 workers across the globe.

What is Cannabis Strategic Ventures' official website?

The official website for Cannabis Strategic Ventures is www.cannabisstrategic.com.

How can I contact Cannabis Strategic Ventures?

Cannabis Strategic Ventures' mailing address is 833 S Spring St Ste 202, Los Angeles, California 90014-2964. The company can be reached via phone at (310) 359-6860.

This page was last updated on 5/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.